Meridian Bioscience Inc VIVO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/05/21 EST
22.35quote price arrow up+0.44 (+2.01%)
Volume
16,993
Close
21.91quote price arrow up+0.84 (+3.99%)
Volume
1,091,376
52 week range
5.51 - 30.65

...

Loading . . .

KEY STATS

  • Open21.01
  • Day High21.98
  • Day Low20.78
  • Prev Close21.07
  • 52 Week High30.65
  • 52 Week High Date02/12/21
  • 52 Week Low5.51
  • 52 Week Low Date03/13/20
  • Market Cap945.42M
  • Shares Out43.15M
  • 10 Day Average Volume0.91M
  • Dividend0.00
  • Dividend Yield-
  • Beta0.54
  • 1 Year % Change166.22

RATIOS/PROFITABILITY

  • EPS (TTM)1.07
  • P/E (TTM)20.51
  • Fwd P/E (NTM)14.47
  • EBITDA (MRQ)81.548M
  • ROE (MRQ)21.06%
  • Revenue (MRQ)253.67M
  • Gross Margin (MRQ)61.60%
  • Net Margin (MRQ)18.21%
  • Debt To Equity (MRQ)27.79%

EVENTS

  • Earnings Date05/02/2021
  • Ex Div Date02/01/2019
  • Div Amount0.125
  • Split Date-
  • Split Factor-

Latest Meridian Bioscience Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Meridian Bioscience, Inc. is a life science company engaged in the development, manufacture, sale and distribution of diagnostic test kits for gastrointestinal, viral, respiratory and parasitic infectious diseases, and elevated blood lead levels, and the manufacture and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/quantitative PCR (qPCR) reagents, nucleotides, competent cells and bioresearch reagents used by researchers and other diagnostic...
David Phillips CPA
Non-Executive Chairman
John Kenny
Chief Executive Officer
Bryan Baldasare
Chief Financial Officer
Lourdes Weltzien
Executive Vice President
Tony Serafini-Lamanna
Executive Vice President
Address
3471 River Hills Dr
Cincinnati, OH
45244
United States